Havah Therapeutics, Inc. — Form D

Havah Therapeutics, Inc. of LONGMONT, CO, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-30. The offering totals $507K, of which $507K was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2024-05-30
• Form: D
• Accession: 0002025011-24-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $507K
• Amount sold: $507K
• Investors: 14
• Date of first sale: 2024-05-17
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-514623

Issuer

• Name: Havah Therapeutics, Inc.
• CIK: 0002025011
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2023
• Address: 2112 ANDREW ALDEN ST, LONGMONT, CO, 80504
• Phone: 3037179446

Officers, directors & promoters (4)

More

• CIK 2025011 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search